Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 06, 2025 05:00 ET | Source: HUTCHMED (China) Limited

HUTCHMED Announces that it has Completed Enrollment of a Phase II Registration Study of Fanregratinib (HMPL-453) for Intrahepatic Cholangiocarcinoma in China

HONG KONG and SHANGHAI and FLORHAM PARK, N.J., March 06, 2025 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM:HCM; HKEX:13) today announces that it has completed enrollment...
March 05, 2025 09:00 ET | Source: NVIDIA

NVIDIA CEO Jensen Huang and Industry Visionaries to Unveil What’s Next in AI at GTC 2025

SANTA CLARA, Calif., March 05, 2025 (GLOBE NEWSWIRE) -- NVIDIA today announced GTC 2025, the world’s premier AI conference, will return March 17-21 to San Jose, Calif. — bringing together the...
March 05, 2025 08:05 ET | Source: Cellectar Biosciences, Inc.

Cellectar Biosciences to Report Full Year Financial Results and Host a Conference Call on Thursday, March 13, 2025

FLORHAM PARK, N.J., March 05, 2025 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (NASDAQ: CLRB), a late-stage clinical biopharmaceutical company focused on the discovery, development and...
March 05, 2025 05:00 ET | Source: HUTCHMED (China) Limited

HUTCHMED Announces Appointment of Independent Non-executive Director and Member of Board Committee

HONG KONG and SHANGHAI and FLORHAM PARK, N.J., March 05, 2025 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (“HUTCHMED” or the “Company”) (Nasdaq/AIM:HCM, HKEX:13) today announces that Mr Wong Tak...
February 28, 2025 08:58 ET | Source: LIS Technologies Inc.

LIS Technologies Inc. Appoints Distinguished Professor J. Gary Eden, Ph.D., as its Chairman of the Advisory Board for Laser Engineering and Innovation

Oak Ridge, Tennessee, Feb. 28, 2025 (GLOBE NEWSWIRE) -- LIS Technologies Inc. (“LIST” or “the Company”), a proprietary developer of advanced laser technology and the only USA-origin and patented...
February 26, 2025 04:00 ET | Source: Microbiotica

Microbiotica presented new data on the mechanism of action of MB097, a clinical-stage drug candidate being developed as a co-therapy in combination with KEYTRUDA® (pembrolizumab) in patients with advanced melanoma

CAMBRIDGE, United Kingdom, Feb. 26, 2025 (GLOBE NEWSWIRE) -- Microbiotica, a clinical-stage biopharma company developing a pipeline of oral precision microbiome medicines called live biotherapeutic...
February 24, 2025 10:00 ET | Source: Yogi Bear’s Jellystone Park Camp-Resorts

Yogi Bear’s Jellystone Park Family Camp-Resort Near Knoxville Opens

Yogi Bear's Jellystone Park Watts Bar Lake near Knoxville, Tenn. has opened. Book now for spring break and summer family camping, glamping and RV stays.
February 24, 2025 07:00 ET | Source: BioCryst Pharmaceuticals, Inc.

BioCryst Reports Fourth Quarter and Full Year 2024 Financial Results and Upcoming Key Milestones

—ORLADEYO net revenue of $124.2 million for Q4 2024 (+36.6 percent y-o-y) and $437.7 million for FY 2024 (+34.3 percent y-o-y)— —FY 2025 ORLADEYO net revenue guidance increased to between $535-$550...
February 24, 2025 07:00 ET | Source: Gylden Pharma Limited

Gylden’s 2025 Strategic Priorities for Advancing Innovative and Transformative Solutions for Infectious Diseases

Clinical trials planned to begin patient enrollment during 2025 to evaluate Gylden’s T cell Priming (TcP) candidates against Dengue (Phase II) and betacoronaviruses (Phase I-II and Phase II) and...
February 21, 2025 07:00 ET | Source: Microbiotica

Microbiotica unveils data on the mechanism of action of MB310, a clinical-stage drug candidate in development for the treatment of ulcerative colitis

CAMBRIDGE, United Kingdom, Feb. 21, 2025 (GLOBE NEWSWIRE) -- Microbiotica, a clinical-stage biopharma company developing a pipeline of oral precision microbiome medicines called live biotherapeutic...